Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from EuroEyes International Eye Clinic Limited ( (HK:1846) ) is now available.
EuroEyes International Eye Clinic Limited has announced the updated list of its board of directors and their roles, effective from September 14, 2025. This reorganization includes both executive and independent non-executive directors, with specific members assigned to the audit, remuneration, and nomination committees. This strategic update is likely to impact the company’s governance and operational oversight, potentially influencing its market positioning and stakeholder relations.
The most recent analyst rating on (HK:1846) stock is a Hold with a HK$3.50 price target. To see the full list of analyst forecasts on EuroEyes International Eye Clinic Limited stock, see the HK:1846 Stock Forecast page.
More about EuroEyes International Eye Clinic Limited
EuroEyes International Eye Clinic Limited operates in the healthcare industry, focusing on providing eye care services. The company specializes in refractive surgery and other eye-related medical procedures, catering to patients seeking vision correction solutions.
Average Trading Volume: 150,891
Technical Sentiment Signal: Hold
Current Market Cap: HK$1.06B
See more insights into 1846 stock on TipRanks’ Stock Analysis page.